A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : CRPC

Search Conditions:
Search Keyword : CRPC
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: CRPC
Appearance Frequency: 2294 time(s)
Long forms: 24

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
castration-resistant prostate cancer
(2110 times)
Neoplasms
(959 times)
AR (584 times)
PSA (331 times)
PCa (227 times)
2006 Improving the outcome of patients with castration-resistant prostate cancer through rational drug development.
castration-resistant PCa
(136 times)
Neoplasms
(59 times)
PCa (91 times)
AR (53 times)
PC (36 times)
2009 Mechanisms mediating androgen receptor reactivation after castration.
colorectal peritoneal carcinomatosis
(19 times)
General Surgery
(10 times)
CRS (7 times)
PCI (6 times)
PIC (5 times)
2008 Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?
cancer peritoneal carcinomatosis
(3 times)
General Surgery
(3 times)
CRS (3 times)
HIPEC (1 time)
IPC (1 time)
2009 Significance of lymph node metastasis in patients with colorectal cancer peritoneal carcinomatosis.
castration-recurrent PCa
(3 times)
Science
(1 time)
AR (3 times)
PCa (3 times)
2009 Androgen receptor abnormalities in castration-recurrent prostate cancer.
castration-recurrent/resistant PCa
(3 times)
Neoplasms
(2 times)
DHT (3 times)
ADT (2 times)
AR (2 times)
2011 Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy.
cancer, patients often progress to castration-resistant disease
(2 times)
Neoplasms
(1 time)
ADT (1 time)
AIS (1 time)
AR (1 time)
2017 Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment.
castrate-resistant prostate cancer patients
(2 times)
Medicine
(1 time)
CTCs (1 time)
DJD (1 time)
GEDI (1 time)
2012 Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device.
cancer transition from androgen-dependent to androgen-independent state
(1 time)
Biochemistry
(1 time)
ADT (1 time)
AR (1 time)
EMT (1 time)
2015 Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer invivo.
10  castration-recurrent/resistant prostate cancer
(1 time)
Urology
(1 time)
AND (1 time)
2018 Mathematical modeling of intracrine androgen metabolism in prostate cancer: Methodological aspects.
11  castration-resistant PCa cell line VCaP
(1 time)
Nuclear Medicine
(1 time)
AA (1 time)
ADT (1 time)
PCa (1 time)
2015 Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy.
12  centered rectangular photonic-crystal
(1 time)
Nanotechnology
(1 time)
DFB (1 time)
HR (1 time)
QCLs (1 time)
2015 10-W pulsed operation of substrate emitting photonic-crystal quantum cascade laser with very small divergence.
13  central renal pyelocalyceal complex
(1 time)
Urology
(1 time)
--- 1979 Nonobstructive fragmentation of central renal pyelocalyceal echo complex.
14  chemotherapy alone, the treatment of peritoneal carcinomatosis from colorectal cancer
(1 time)
General Surgery
(1 time)
CRS (1 time)
IPC (1 time)
2013 Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?
15  chronic radiation proctocolitis
(1 time)
Gastroenterology
(1 time)
APC (1 time)
2011 The incidence of bacteraemia after argon plasma coagulation in patients with chronic radiation proctocolitis.
16  cisplatin/etoposide-resistant prostate cancer
(1 time)
Antineoplastic Agents
(1 time)
G-CSF (1 time)
MTD (1 time)
TNBC (1 time)
2018 A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors.
17  concentrates prepared from Channa striatus
(1 time)
Chemistry
(1 time)
--- 2012 Physico-chemical, amino acid composition, functional and antioxidant properties of roe protein concentrates obtained from Channa striatus and Lates calcarifer.
18  confound treatment of this 'castration resistant' stage of PCa
(1 time)
Neoplasms
(1 time)
AR (1 time)
DBD (1 time)
LBD (1 time)
2018 Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer.
19  consecutive rising PSAs
(1 time)
Urology
(1 time)
ADT (1 time)
EHR (1 time)
PSADT (1 time)
2015 Estimating high-risk castration resistant prostate cancer (CRPC) using electronic health records.
20  coordinating rehabilitation and palliative care
(1 time)
Medicine
(1 time)
--- 2018 [Coordinating rehabilitation and palliative care].
21  corticosteroid-refractory refractory prostate cancer
(1 time)
Nephrology
(1 time)
ALP (1 time)
DEX (1 time)
LDH (1 time)
2011 Docetaxel as a vital option for corticosteroid-refractory prostate cancer.
22  CR prostate cancer
(1 time)
Biological Science Disciplines
(1 time)
CR (1 time)
2018 Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer.
23  cumulated rate of permanent colostomy
(1 time)
Neoplasms
(1 time)
CR (1 time)
EBRT (1 time)
2012 Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial.
24  hormone-refractory 'castrate-resistant' PC
(1 time)
Molecular Biology
(1 time)
AR (1 time)
PCs (1 time)
PHB (1 time)
2012 Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.